Published • loading... • Updated
MEDP Investors Have Opportunity to Lead Medpace Holdings, Inc. Securities Fraud Lawsuit
Rosen Law Firm says investors may seek lead plaintiff status as the suit alleges Medpace hid backlog cancellation risks and offered inflated growth expectations.
- The Rosen Law Firm filed a securities class action lawsuit against Medpace Holdings, Inc., alleging the company made materially false or misleading statements regarding its backlog cancellation rates during the Class Period.
- According to the lawsuit, Medpace Holdings, Inc. touted "well behaved" cancellation rates while concealing that cancellations were not caused by weak business, providing investors with overly positive growth expectations that could not maintain the projected 1.15 book-to-bill ratio.
- Founding partner Laurence Rosen, whose firm has recovered hundreds of millions of dollars for investors, was named a "Titan of Plaintiffs' Bar" by Law360 in 2020, highlighting the firm's track record in securities class actions.
- Joining the class action allows investors who purchased common stock between April 22, 2025, and February 9, 2026, to seek potential recovery without paying out-of-pocket costs, as the firm operates on a contingency fee basis.
- Deadlines for serving as lead plaintiff are court-imposed, requiring investors to move the Court by June 8, 2026, though shareholders may choose to remain absent class members with no requirement to participate to share in recovery.
Insights by Ground AI
48 Articles
48 Articles
GOSS Investors Have Opportunity to Lead Gossamer Bio, Inc. Securities Fraud Lawsuit with the ...
LOS ANGELES, May 08, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Gossamer Bio, Inc. (“Gossamer” or “the Company”) (NASDAQ: GOSS ) for violations of §§10(b)…
·Nebraska, United States
Read Full Article
ALIT Investors Have Opportunity to Lead Alight, Inc. Securities Fraud Lawsuit with the Schall ...
LOS ANGELES, May 07, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Alight, Inc. (“Alight” or “the Company”) (NYSE: ALIT ) for violations of §§10(b) and…
Charleston Gazette-Mail+3 Reposted by 3 other sources
POET Investors Have Opportunity to Lead POET Technologies Inc. Securities Fraud Lawsuit Filed by The Rosen Law Firm
·Charleston, United States
Read Full ArticleCoverage Details
Total News Sources48
Leaning Left6Leaning Right5Center17Last UpdatedBias Distribution61% Center
Bias Distribution
- 61% of the sources are Center
61% Center
L 21%
C 61%
R 18%
Factuality
To view factuality data please Upgrade to Premium
